Pharma Focus Asia provides the senior management with the direction they need to make the strategic decisions necessary to capture market share. Our readers represent the leading players in the Asian pharma market and the top global players-your target market. And our dedicated team of researchers ensure that the distribution list is unrivalled in its quality and reach. The readers of Pharma Focus Asia have requested to receive the publication because they recognise the value of its independent reporting. Taking a closer look at the quality of writing and the journalistic integrity, it clearly makes Pharma Focus Asia a powerful prospect for readers.
Pharma Focus Asia's circulation is spread across the following segments:
|Biotechnology||Machinery and Instruments|
|Contract Research||Speciality Pharmaceuticals|
Pharma Focus Asia is published quarterly with a paid circulation of over 13,500 hard book copies and an estimated readership of 95,000 key decision makers globally. More than 90,000 readers receive e-book copies. This translates into an estimated readership base of over 190,000. (Source: Publisher's Survey)
Our readers represent the most important organisations in the Asian and global pharmaceutical market.